Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04849169 · ClinicalTrials.gov registry record · NA
Investigation of the Ringer Perfusion Balloon Catheter
A NA study, sponsored by Vascular Solutions.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04849169 is a NA study that has completed, run by Vascular Solutions. The registered enrollment target is 30 participants.
The verdict
NCT04849169, a NA study, has completed, sponsored by Vascular Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate reasonable assurance that the Ringer catheter can be safely used to manage hemorrhage due to coronary vessel perforations while facilitating distal perfusion under the conditions of use prescribed in the labeling.
Interventions
- DEVICE Experimental
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-07-18 |
| Est. Completion | 2023-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04849169
The ClinicalTrials.gov registry entry for NCT04849169 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vascular Solutions, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Experimental is the first listed.
NCT04849169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04849169 about?
NCT04849169 is a clinical study titled "Investigation of the Ringer Perfusion Balloon Catheter". The objective of this study is to demonstrate reasonable assurance that the Ringer catheter can be safely used to manage hemorrhage due to coronary vessel perforations while facilitating distal perfusion under the conditions of use prescribed in the labeling.
What is the current status of trial NCT04849169?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-07-18. Estimated completion is 2023-11-21.
What interventions are being tested in trial NCT04849169?
The interventions under investigation include: Experimental (DEVICE).
Who is sponsoring clinical trial NCT04849169?
This trial is sponsored by Vascular Solutions, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.